Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Crlf1em1flox/Cya
Common Name:
Crlf1-flox
Product ID:
S-CKO-01868
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Crlf1-flox
Strain ID
CKOCMP-12931-Crlf1-B6N-VA
Gene Name
Crlf1
Product ID
S-CKO-01868
Gene Alias
CLF-1; CRLM-3; CRLM3; NR6; NR6.1
Background
C57BL/6NCya
NCBI ID
12931
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:1340030
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Crlf1em1flox/Cya mice (Catalog S-CKO-01868) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000008032
NCBI RefSeq
NM_018827
Target Region
Exon 2~6
Size of Effective Region
~3.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
CRLF1, or cytokine receptor-like factor 1, is a soluble type I cytokine receptor. Cytokines and their receptors are crucial in regulating immune function, inflammation, haematopoiesis, cell growth, and differentiation. CRLF1, upon interacting with its specific cytokine ligands, triggers intracellular signalling cascades, which can impact gene expression in target cells, thus influencing processes like cell proliferation, differentiation, or activation [1].

In cardiac fibrosis, CRLF1 is predominantly expressed in cardiac fibroblasts. Its expression is up-regulated in fibrotic models. Gain-and loss-of-function experiments in neonatal mice cardiac fibroblasts showed that CRLF1 overexpression promotes fibrosis, while silencing has the opposite effect, with CRLF1 acting via the ERK1/2 signalling pathway [2].

In ovarian cancer, CRLF1 is part of mTORC2, enhancing AKT Ser473 phosphorylation through SIN1, inhibiting pyroptosis, and conferring chemoresistance. Binding-defective CRLF1 variants can reverse this, promoting pyroptosis and chemosensitization [3].

In the ligamentum flavum hypertrophy, CRLF1 is up-regulated. TGF-β1 increases its mRNA expression through the SMAD3 pathway, and CRLF1 enhances fibrosis via the ERK pathway. Knockdown of CRLF1 reduces fibrosis [4].

In papillary thyroid carcinoma, CRLF1 promotes proliferation and metastasis. It binds MYH9 to enhance its own stability, activates the ERK pathway, and up-regulates ETV4, which is associated with poor prognosis [5]. Also, CRLF1 promotes the malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways [8].

In osteochondral repair, BMSCs overexpressing CRLF1 improve osteochondral defect repair. A homodimeric CRLF1 complex released by BMSCs enhances repair via inhibiting catabolic events in chondrocytes and stimulating chondrogenic differentiation of precursor cells [6].

In intervertebral disc degeneration, the CRLF1/CLCF1 heterodimer activates JAK/STAT3 signalling, accelerating nucleus pulposus cell senescence. Targeting CRLF1 reduces extracellular matrix degradation and alleviates cell senescence [7].

Mutations in CRLF1 can cause familial achalasia and are also associated with Crisponi or cold-induced sweating syndrome type 1 [9].

In conclusion, CRLF1 plays diverse and significant roles in various biological processes and disease conditions. Through gene knockout or conditional knockout models in mice and other loss-of-function experiments, its functions in cardiac fibrosis, cancer, ligamentum flavum hypertrophy, osteochondral repair, and intervertebral disc degeneration have been revealed. These findings provide potential therapeutic targets for related diseases.

References:
1. Crisponi, Laura, Buers, Insa, Rutsch, Frank. 2022. CRLF1 and CLCF1 in Development, Health and Disease. In International journal of molecular sciences, 23, . doi:10.3390/ijms23020992. https://pubmed.ncbi.nlm.nih.gov/35055176/
2. Luo, Shenjian, Yang, Zhi, Chen, Ruxin, Li, Jin, Zhang, Huijie. . Cytokine receptor-like factor 1 (CRLF1) promotes cardiac fibrosis via ERK1/2 signaling pathway. In Journal of Zhejiang University. Science. B, 24, 682-697. doi:10.1631/jzus.B2200506. https://pubmed.ncbi.nlm.nih.gov/37551555/
3. Xiang, Cong, Chen, Li, Zhu, Shilei, Lei, Yunlong, Cai, Xiongwei. 2024. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer. In Cell death & disease, 15, 662. doi:10.1038/s41419-024-07035-4. https://pubmed.ncbi.nlm.nih.gov/39256356/
4. Zheng, Zhenyu, Ao, Xiang, Li, Peng, Zhang, Zhongmin, Wang, Liang. 2020. CRLF1 Is a Key Regulator in the Ligamentum Flavum Hypertrophy. In Frontiers in cell and developmental biology, 8, 858. doi:10.3389/fcell.2020.00858. https://pubmed.ncbi.nlm.nih.gov/33072735/
5. Yu, Shi-Tong, Sun, Bai-Hui, Ge, Jun-Na, Chen, Wei-Sheng, Lei, Shang-Tong. 2020. CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis. In Frontiers in endocrinology, 11, 535. doi:10.3389/fendo.2020.00535. https://pubmed.ncbi.nlm.nih.gov/32982961/
6. Zhang, Fenglin, Clair, Andrew J, Dankert, John F, Campbell, Kirk A, Kirsch, Thorsten. 2024. Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair. In Cells, 13, . doi:10.3390/cells13090757. https://pubmed.ncbi.nlm.nih.gov/38727293/
7. Zhu, Jian, Huang, Yuming, Lei, Linchuan, Wang, Jianru, Zheng, Zhaomin. 2025. CRLF1/CLCF1 heterodimer involvement in intervertebral disc degeneration via exacerbation of extracellular matrix degradation and nucleus pulposus cell senescence. In Osteoarthritis and cartilage, 33, 574-589. doi:10.1016/j.joca.2025.02.773. https://pubmed.ncbi.nlm.nih.gov/39986601/
8. Yu, Shi-Tong, Zhong, Qian, Chen, Ren-Hui, Zeng, Mu-Sheng, Huang, Xiao-Ming. 2018. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways. In Cell death & disease, 9, 371. doi:10.1038/s41419-018-0352-0. https://pubmed.ncbi.nlm.nih.gov/29515111/
9. Busch, A, Žarković, M, Lowe, C, Rutsch, F, Hübner, C A. 2017. Mutations in CRLF1 cause familial achalasia. In Clinical genetics, 92, 104-108. doi:10.1111/cge.12953. https://pubmed.ncbi.nlm.nih.gov/27976805/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest